AMINO ACIDS POWDER FORM

Brand	Owner	Address	Description
CREABEV	GLANBIA NUTRITIONALS LIMITED	Glanbia House Kilkenny R95E866 Ireland	Amino acids in powder form comprised in whole or significant part of creatine for laboratory or research use; proteins for use in manufacture, namely, amino acids in powder form comprised in whole or significant part of creatine; amino acid compounds for industrial purposes, namely, amino acids in powder form comprised in whole or significant part of creatine for the industrial manufacturing of dietary and nutritional beverages and supplements;
	Where the owner name is not linked, that owner no longer owns the brand

Technical Examples

The present invention relates to an NST500 compound of general formula (I): comprising the following components: X1-X2-{(X3)a/X4/X5}-X6, wherein: X1 stands for a saturated or unsaturated fatty acid residue comprising 6-20 carbon atoms; or a cysteine residue bound through a thioether bond to a prenyl group comprising 5-20 carbon atoms; said residue being linked to the adjacent component of the compound through an amide bond; X2 is 0; X3 comprises 1-6 amino acids, of which 1-6 are positively charged and 0-2 are negatively charged, the other amino acid residues being polar uncharged amino acids; X4 comprises 1-6 amino acids, of which 1-2 are aromatic amino acids, the other amino acids being selected among polar uncharged amino acids and hydrophobic aliphatic amino acids; X5 comprises 6-8 amino acids, of which 4-6 are positively charged and 0-2 are negatively charged, the other amino acid residues being polar uncharged amino acids, wherein the amino acids form a cyclic structure; X6 is a compound of general formula II, wherein Z stands for a spacer group selected among alkane and alkene containing 1-5 carbon atoms, J stands for a functional group selected among amines, thiols, alcohols, carboxylic acids and esters, aldehydes and alkyl halides; U is 0 or is selected among a labeling group; wherein a stands for an integer of 1-3; and the groups X3, X4 and X5 being located at various places in the compound; as well as functional equivalents thereof and/or compounds having the same biological activity thereto. The present also relates to pharmaceutical compositions and methods of using the same.